The Latest in Outcomes
eGenesis Announces Another New Hampshire Man Gets a Pig Kidney as Transplant Trials Are Poised to Start
eGenesis Announces Another New Hampshire Man Gets a Pig Kidney as Transplant Trials Are Poised to Start
Read Press Release
The Latest in Outcomes
Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia
Tyra Biosciences Announces FDA Orphan Drug Designation
Read Press Release
The Latest in Outcomes
Variant Bio Turns Toward Discovery of Novel Medicines, Marking a New Chapter of Growth for the Company
Variant Bio Turns Toward Discovery of Novel Medicines
Read Press Release
The Latest in Outcomes
Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells without Preconditioning in Non-Human Primates with Intact Immune Systems
Be Biopharma Study Shows First Demonstration of Rapid Engraftment of B Cells
Read Press Release
The Latest in Outcomes
Kelonia Therapeutics Presents Research Highlighting Potential of iGPS™ in vivo Gene Therapy to Bring Safe, Effective CAR T Therapies to Common Medical Practice for Treatment of All Multiple Myeloma Patients
Kelonia Therapeutics Presents Research Highlighting Potential of iGPS™ in vivo Gene Therapy
Read Press Release
The Latest in Outcomes
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial
Read Press Release
The Latest in Outcomes
Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical Trials
Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical Trials
Read Press Release Empowering the Next Generation of Healthcare
The healthcare sector has reached an inflection point. Technology and innovation are allowing the integration of physicians, payers, and patients to provide better outcomes and challenge the status quo. At Alta, we believe healthcare ultimately should work for patients. We are dedicated to helping entrepreneurs build high-impact companies.
Choose an option below to login.